Proximity Systems Provides Results from NSF International Testing of their UV Light Disinfection Unit

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates. By bringing these companies together, Veranex combines the industry’s key pillars of design and engineering, regulatory, clinical, and market access into a single-source solution.

Proximity Systems VP of Business Development and Senior Care Steve Reinecke explained why it was imperative to have an outside source test their product: “NSF International is a leading provider of public health and safety-based risk management solutions,” he said. “Their independent test of UV-CLEAN took place in an accredited, state-of-the-art lab with robust instrumentation and technologies and was conducted by highly experienced personnel. For those reasons, we’re extremely confident in the results.”

As part of the test, different keyboard keys were inoculated with C. diff and MRSA before being exposed to UVC light via the UV-CLEAN unit. Multiple exposure times were evaluated also. After post-swabbing and subsequent incubation, the following reductions were calculated and reported: There was a 91.1% reduction in C. diff after 10 minutes of UVC exposure; there was a 99.996% reduction in C. diff after 30 minutes of UVC exposure; there was a 99.996% reduction in MRSA after 10 minutes of UVC exposure; and there was a 99.998% reduction in MRSA after 15 minutes of UVC exposure.

Proximity Systems’ CEO Jeremy Goza is excited about the successful testing.

“We are really pleased with how the testing was conducted and the results that were reported,” he said. “These tests validated what we already knew about our product, that UV-CLEAN is effective at killing harmful pathogens found on high touch surfaces.”

The clinical testing facilitated a common scenario at health care facilities across the world where infection-causing pathogens are transmitted by the hands of health care works from high touch surfaces like keyboards, workstations on wheels (WOWs) or portable medical equipment (PME).

“Patients are at a higher risk to acquire a hospital acquired infection (HAI),” said Reinecke. “The NSF International testing proved Proximity’s disinfection device UV-CLEAN is effective at eliminating bacteria, making it the right complement to existing cleaning and hand hygiene protocols.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles